Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-22

Clinical Trial Update: Primary Progesterone Therapy for Operable Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating primary progesterone therapy for operable breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Primary progesterone therapy (progesterone)

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Breast Neoplasms | Phase 2, Phase 3 | Status: COMPLETED